Functional Microbiomics, Inflammation and Pathogenicity
Project Number5P20GM125504-08
Former Number3P20GM125504-04
Contact PI/Project LeaderLAMONT, RICHARD J
Awardee OrganizationUNIVERSITY OF LOUISVILLE
Description
Abstract Text
Project Summary/Abstract
In the past few decades, the fields of microbiology and immunology have undergone a renaissance, driven in
part by technological advances establishing that the human microbiome can play a role in a number of
fundamental aspects of human health and disease, in many instances through the interface with host innate
immunity. The immune system functions to restrict the potential for damage caused by the microbiota while
simultaneously minimizing destructive inflammatory responses. Disruption of the intensity, duration or physical
location of inflammation, however, can contribute to disease. Advances in our understanding of the microbiome,
and its regulation by environmental factors, along with a realization that inflammatory processes are at the core
of a number of common diseases, necessitates a cross-disciplinary perspective that accommodates the host-
microbe interaction in toto. The major goal of this Phase 2 Cobre is to continue to develop and expand our
thematic multidisciplinary research center for the study of the interface between the microbiome, inflammation
and pathogenicity within a framework to develop the careers of junior investigators. We have assembled a team
of junior investigators with complementary expertise and outstanding potential, and have partnered these project
leaders with well-qualified and dedicated mentors. An integrated set of projects will make novel connections
between inflammatory processes and bacterial pathogenicity, and establish the basis for the development of
novel therapeutics and delivery methods. We will create a multidisciplinary program in research, training,
mentoring and career development that will facilitate and accelerate the transition of junior faculty to independent
extramural funded status. Research will be support by a Functional Microbiomics Core that will provide germ
free animal facilities, anaerobic culture capability, microbiome sequencing and bioinformatics, assay of
inflammatory markers, along with whole animal imaging and intravital microscopy. An Administrative Core will
co-ordinate activities and provide additional biostatistical support, along with a Pilot Project program to ensure a
pipeline of investigators. Institutional commitment through a university funded Center will ensure sustainability
of the thematic research program.
Public Health Relevance Statement
Project Narrative
The University of Louisville COBRE in Functional Microbiomics, Inflammation and Pathogenicity is a unique
thematic research center. COBRE scientists comprise a multidisciplinary group of senior mentors and junior
investigators on a pathway to independence, who are focusing on diseases that involve complex interactions
between microbial challenge and host inflammatory responses. Outcomes of this research may lead to the
development of novel therapeutic agents and delivery systems to protect against a number of chronic and difficult
to treat conditions.
No Sub Projects information available for 5P20GM125504-08
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P20GM125504-08
Patents
No Patents information available for 5P20GM125504-08
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P20GM125504-08
Clinical Studies
No Clinical Studies information available for 5P20GM125504-08
News and More
Related News Releases
No news release information available for 5P20GM125504-08
History
No Historical information available for 5P20GM125504-08
Similar Projects
No Similar Projects information available for 5P20GM125504-08